Company Profile
Hunan Xiangzhong Pharmaceutical, founded in 1969 and part of China Resources Double-Crane since 2018, is an integrated producer of APIs and both Western and Chinese medicines.
It is a major anti-epileptic drug base in China with nine dosage forms and 83 products; magnesium valproate sustained-release tablets and valpromide tablets are exclusive products.
Contact
Address: Daxing South Road No. 18, Baoqing Industrial Zone, Shaoyang, Hunan, China. Tel: 0739-5323526. Email: crdc_xzzy_gw@dcpc.com. Web: https://www.dcpc.com/xzzy/.